FR2615104B1 - Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme - Google Patents

Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme

Info

Publication number
FR2615104B1
FR2615104B1 FR878706785A FR8706785A FR2615104B1 FR 2615104 B1 FR2615104 B1 FR 2615104B1 FR 878706785 A FR878706785 A FR 878706785A FR 8706785 A FR8706785 A FR 8706785A FR 2615104 B1 FR2615104 B1 FR 2615104B1
Authority
FR
France
Prior art keywords
protease
plasmodium falciparum
peptide substrates
medicaments
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR878706785A
Other languages
English (en)
Other versions
FR2615104A1 (fr
Inventor
Joseph Schrevel
Michel Monsigny
Roger Mayer
Francois Xavier Bernard
Isabelle Picard
Philippe Louis Francois Lawton
Philippe Grellier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR878706785A priority Critical patent/FR2615104B1/fr
Priority to FR8804948A priority patent/FR2615395A1/fr
Priority to PCT/FR1988/000249 priority patent/WO1988008717A2/fr
Publication of FR2615104A1 publication Critical patent/FR2615104A1/fr
Application granted granted Critical
Publication of FR2615104B1 publication Critical patent/FR2615104B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR878706785A 1987-05-14 1987-05-14 Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme Expired FR2615104B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR878706785A FR2615104B1 (fr) 1987-05-14 1987-05-14 Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme
FR8804948A FR2615395A1 (fr) 1987-05-14 1988-04-14 Utilisation comme ingredients actifs, dans la pr eparation de medicaments contre le paludisme, de derives peptidiques comprenant une sequence constituant un substrat pour une protease de plasmodium falciparum
PCT/FR1988/000249 WO1988008717A2 (fr) 1987-05-14 1988-05-16 Peptides actifs contre le paludisme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR878706785A FR2615104B1 (fr) 1987-05-14 1987-05-14 Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme

Publications (2)

Publication Number Publication Date
FR2615104A1 FR2615104A1 (fr) 1988-11-18
FR2615104B1 true FR2615104B1 (fr) 1989-08-18

Family

ID=9351099

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878706785A Expired FR2615104B1 (fr) 1987-05-14 1987-05-14 Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme

Country Status (2)

Country Link
FR (1) FR2615104B1 (fr)
WO (1) WO1988008717A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667578B2 (en) * 1992-08-27 1996-03-28 Deakin Research Limited Retro-, inverso-, and retro-inverso synthetic peptide analogues
US6395897B1 (en) 1999-03-02 2002-05-28 Boehringer Ingelheim Pharmaceuticals, Inc. Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910005702B1 (ko) * 1982-12-27 1991-08-02 앵스띠뛰 빠스뙤르 말라리아 기생충에 대한 방어항체를 유도하는 폴리펩티드 단편을 함유한 면역원 조성물의 제조방법

Also Published As

Publication number Publication date
WO1988008717A2 (fr) 1988-11-17
FR2615104A1 (fr) 1988-11-18
WO1988008717A3 (fr) 1988-12-01

Similar Documents

Publication Publication Date Title
FR2590262B1 (fr) Nouveaux polyanhydrides, leur preparation et leur utilisation comme matrices de principes pharmacologiquement actifs
FR2620451B1 (fr) Nouveaux inhibiteurs de la renine, leur preparation et leur utilisation comme medicaments
AU1075001A (en) Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
NO176920C (no) Enzymelektrode
DE69835441D1 (de) Behandlung von t-helfer zel typ 2 vermittelten immunkrankheiten mit retinoid antagonisten
DE59007178D1 (de) Verwendung alkylierter Polyethylenimine als gallensäureadsorbierende Arzneimittel sowie pharmazeutische Präparate.
FR2590902B1 (fr) Nouveaux derives de la calcitonine, leur preparation et leur utilisation comme medicaments
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
ES2013639B3 (es) Nuevas composiciones tensioactivas a base de esteres fosforicos, su procedimiento de preparacion y su aplicacion a la formulacion de materias activas.
ATE239709T1 (de) Racemisches huperzin a
IT8620404A1 (it) Esteri grassi dienici oppure trienici di eritromicina a, loro procedimento di preparazione e composizioni farmaceutiche i cosmetiche che li contengono
IT1222412B (it) Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
DK480685D0 (da) Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum
AU5293686A (en) Polypeptides comprising repeat units of plasmodium falciparum CS protein, and production thereof
FR2560196B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
IT1204556B (it) Esteri retinoici di antibiotici,loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono
FR2615104B1 (fr) Nouvelle protease de plasmodium falciparum, anticorps diriges contre cette protease, substrats peptidiques specifiques de ladite protease, et leur utilisation comme medicament contre le paludisme
IT1228241B (it) Acido 7-ammino-3-propenilcefalosporanico e suoi esteri, e relativo procedimento di preparazione
FR2630430B1 (fr) Nouvelles compositions vitreuses luminescentes, leur preparation et leur application
IL65922A (en) Preparation of apovincaminic acid esters,certain novel optically active trans-derivatives thereof and pharmaceutical compositions containing them
IT1235166B (it) Peptidi contenenti silicio, loro preparazione e loro impiego come medicamenti
AU585422B2 (en) Production of human serum albumin in bacillus
DK513188A (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
FR2575159B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation, leur utilisation comme medicaments et les compositions pharmaceutiques les contenant
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture

Legal Events

Date Code Title Description
ST Notification of lapse